STIL and cancer: In the GSE13507 dataset, we also observed that the overall survival (OS), cancer-specific survival (CSS), progression-free survival (PFS), and recurrence-free survival (RFS) of patients with higher STIL expression showed poor outcomes than that of patients with lower STIL expression (Fig. 1L, M, Additional file 1: Fig. S3A, B).